Ottawa, Ontario, June 25, 2026 (GLOBE NEWSWIRE) — A new national effort is underway to better support internationally educated occupational therapists (IEOTs) as they build their careers in Canada. The Canadian Association of Occupational Therapy (CAOT) is proud to announce the upcoming launch of The Canadian Hub for Internationally Educated Occupational Therapists: Your First Stop to OT Practice in Canada.
Pizza Has Gone Cold. Domino’s Is Still Worth a Look.
Formic Acid Market Size to Surpass USD 4.00 Billion by 2035 as Demand Grows Across Agriculture, Chemicals, and Pharmaceuticals | SNS Insider
U.S. Market Projected to Expand USD 0.76 Billion by 2035, While Europe Advances Toward USD 0.51 Billion on EU Antibiotic Ban and Industrial Demand
Form 8.5 (EPT/RI) – Pharos Energy Plc
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”
European Commission report supports cBrain’s expansion of environmental permitting activities in Europe
Nokia to provide intelligent connectivity for Finnish Border Guard counter-drone initiative nationwide
Press Release
Nokia to provide intelligent connectivity for Finnish Border Guard counter-drone initiative nationwide
The New Push to Ready Millions for AI Career Upheaval
Cloud Discovery Market Size to Surpass $9.77 Billion by 2035 as Multi-Cloud Adoption and Shadow IT Challenges Drive Enterprise Demand | Report by SNS Insider
The U.S. Cloud Discovery Market is Expected to Grow from $0.60 Billion in 2025 to $3.06 Billion by 2035, While Europe is Projected to Expand from $0.39 Billion to $1.42 Billion, Fueled by Rising Multi-Cloud Complexity, Strong Cloud Security Investments, and Regulatory Requirements Including GDPR, NIS2, and DORA Across Enterprise Environments
Breast Cancer Liquid Biopsy Market Size to Reach USD 3.42 Billion by 2035 | SNS Insider
The U.S. Breast Cancer Liquid Biopsy Market is projected to grow from USD 0.39 Billion in 2025 to USD 0.84 Billion by 2035, while Europe is expected to expand from USD 0.35 Billion to USD 0.78 Billion, driven by increasing companion diagnostic adoption, expanding precision oncology programs, and growing utilization of ctDNA testing.
Share Buyback Transaction Details June 18 – June 24, 2026
Atos retenu sur trois lots du marché AMOA SI de la Centrale d’Achat de l’Informatique Hospitalière (CAIH)
Dolman Law Group Files Class Action Against Roblox, Alleging Child Labor Exploitation
San Francisco, CA, June 25, 2026 (GLOBE NEWSWIRE) — A new class action lawsuit filed in federal court alleges that Roblox Corporation built a multi-billion-dollar business model on unpaid and underpaid child labor.
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
STOCKHOLM, Sweden, June 25, 2026 – AnaCardio, a clinical stage biopharmaceutical company developing novel drugs to treat heart failure, today announced the publication in The Lancet of results from its Phase 1b/2a GOAL-HF1 study evaluating AC01, a first-in-class, oral calcium-sensitising contractile agent, in patients with heart failure with reduced ejection fraction (HFrEF). The results showed a favourable safety and tolerability profile, dose-proportional pharmacokinetics with confirmed target engagement. In exploratory efficacy analyses, numerical rapid and sustained improvements in haemodynamics and cardiac structure and function were observed on top of optimised guideline-directed medical therapy (GDMT).
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and commercialization
KNL awarded position on UK defence framework
KNL er kvalifisert til rammeavtale med det britiske forsvaret
(Fornebu, Norge / Oulu, Finland, 25. juni 2026) KNL, et datterselskap av Telenor Group som leverer kommunikasjonssystemer til forsvarssektoren, er utpekt som godkjent leverandør under Storbritannias Tactical Communication Systems Framework (RM6393).
The Silent Portfolio: A Quarter of European Wealth Managers Cannot See the Majority of Their Clients’ Digital Assets
New CoinShares survey of 261 advisers across five markets finds that firm policy, not knowledge or client demand, determines whether crypto exposure is managed, or invisible
ALPEX ACQUISITION CORPORATION ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) — Alpex Acquisition Corporation (NASDAQ: ALPXU) (“Alpex”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under “ALPXU” beginning June 25, 2026. Each unit consists of one Class A ordinary share, one redeemable warrant, and one right to receive one-fourth of one Class A ordinary share upon consummation of an initial business combination. Each whole redeemable warrant entitles the holder thereof to purchase one Class A ordinary share at an exercise price of $11.50 per share. Upon separate trading, the Class A ordinary shares, warrants and rights are expected to be listed on Nasdaq under “ALPX,” “ALPXW,” and “ALPXR,” respectively.